Mission
NEUROSERVICE's mission is to provide answers about compound effects in the Central Nervous System from a neuronal network down to a single protein level in brain and spinal cord acute slices.
NEUROSERVICE provides 3 types of electro-physiological-based services:
- Standardized assays (in house development & validation)
- Industrialization of assays:
- Transfer of customer protocols
- Re-validation of protocols (from literature or other sources)
- Complete R&D support for customer research projects
Expertise
NEUROSERVICE evaluates your molecules on the CNS thanks to functional electro- physiological assays (Multi-Electrode Arrays and Patch-Clamp) performed by high-skilled scientists within industrial processes. High-quality service, mid-throughput, robust and reproducible data as well as short delays are guaranteed by NEUROSERVICE.
-
Join us at SOT ToxExpo, March 11-15, 2012 in San Francisco
On 17/01/2012
Visit us at booth #322 and see our assays in acute brain slices focusing Safety & Toxicology!
+ read more -
NEUROSERVICE will exhibit at the 6th Drug Discovery for Neurodegeneration conference
On 16/01/2012
The conference will be held in New York City, February 12-14, 2012.
+ read more -
Thanks for visiting us at Neuroscience 2011 in Washington !
On 28/11/2011
Neuroservice was pleased to exhibit at Neuroscience 2011 in Washington, November 13-16, and present new standardized assay and full scope of services.
+ read more
-
NEUROSERVICE will attend the 7th Annual CHDI Foundation meeting, Feb 27- March 1, 2012 in Palm Springs, CA
On 16/01/2012
NEUROSERVICE will attend the 7th Annual CHDI Foundation meeting.
+ read more -
Select your compounds devoid of any undesired CNS side effects
On 16/01/2012
NEUROSERVICE validated a range of in vitro electrophysiological based assays able to predict major proconvulsant liabilities.
+ read more -
Your compound targets the M1 mACh Receptor ? Discover the new assay of NEUROSERVICE
On 16/09/2011
NEUROSERVICE has validated a new in vitro electrophysiological test to evaluate the pharmacological activity/profile of your compound at M1 receptors.
+ read more -
New functional assay on GABA-A receptors in acute slices
On 14/01/2011
NEUROSERVICE has validated a new test to investigate any compound effects on the GABA-A receptors and inhibitory synaptic transmission.
+ read more -
Document direct effect of compounds on NMDA receptors !
On 21/10/2010
For research focused on neurodegenerative diseases, ischemia, schizophrenia, NEUROSERVICE has developed a new functional assay to screen compounds on NMDA receptors.
+ read more